L01ED Anaplastic lymphoma kinase (ALK) inhibitors

Place in the ATC system

1. L Antineoplastic and immunomodulating agents 1,069 drugs
   1. L01 Antineoplastic agents 616 drugs
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
         1. L01ED Anaplastic lymphoma kinase (ALK) inhibitors 4 drugs
            1. L01ED01 Crizotinib 1 drug
            2. L01ED02 Ceritinib 1 drug
            3. L01ED03 Alectinib 1 drug
            4. L01ED05 Lorlatinib 1 drug

Active ingredients of the class

• Alectinib (alectinib hydrochloride) 1 drug
• Ceritinib 1 drug
• Crizotinib 1 drug
• Lorlatinib 1 drug

Drugs in the class and its subclasses

Other classes of the same level

• L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
• L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
• L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 3 drugs
• L01EE Mitogen-activated protein kinase (MEK) inhibitors 5 drugs
• L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
• L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 1 drug
• L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
• L01EJ Janus-associated kinase (JAK) inhibitors 3 drugs
• L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
• L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
• L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 3 drugs
• L01EX Other protein kinase inhibitors 30 drugs

Other names of the drug class

• English (United Kingdom): L01ED Anaplastic lymphoma kinase (ALK) inhibitors
• German: L01ED Anaplastische Lymphomkinase (ALK)-Inhibitoren
• German (Austria): L01ED Anaplastische Lymphomkinase (ALK)-Inhibitoren
• Italian: L01ED Inibitori della chinasi del linfoma anaplastico
• Turkish: L01ED Anaplastik lenfoma kinaz (ALK) inhibitörleri
• German (Switzerland): L01ED Anaplastische Lymphomkinase (ALK)-Inhibitoren
• Italian (Switzerland): L01ED Inibitori della chinasi del linfoma anaplastico